Compare PAYP & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYP | PEN |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.9B |
| IPO Year | 2026 | 2015 |
| Metric | PAYP | PEN |
|---|---|---|
| Price | $20.96 | $329.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 17 |
| Target Price | $25.54 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 2.8M | 546.4K |
| Earning Date | 08-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | N/A | $14.34 |
| Revenue Next Year | N/A | $13.71 |
| P/E Ratio | ★ N/A | $73.23 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $17.80 | $221.26 |
| 52 Week High | $24.89 | $362.41 |
| Indicator | PAYP | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 54.48 | 37.45 |
| Support Level | $18.82 | $326.58 |
| Resistance Level | $24.89 | $338.99 |
| Average True Range (ATR) | 1.91 | 2.32 |
| MACD | -0.20 | -0.30 |
| Stochastic Oscillator | 37.37 | 25.00 |
PayPay Corp is a Japan-based financial technology provider operating a digital finance platform that integrates payments, banking, credit, and investment services for individuals and businesses. Its platform connects users and merchants, facilitating a cashless ecosystem and providing an all-in-one solution for daily financial activities. The company operates in two reportable segments: i) Payment segment and ii) Financial service segment. The majority of the company's revenue is derived from the Financial service segment, which includes internet banking services, securities intermediary services and PayPay Point investment-related services, and loan management services. Geographically, it operates predominantly in Japan.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.